Inhibitory Effects of Trehalose on Malignant Melanoma Cell Growth: Implications for a Novel Topical Anticancer Agent on the Ocular Surface
Figure 5
Sizes of the subconjunctivally inoculated melanoma cell 28 days after inoculation treatments with or without trehalose instillation along the tangential (a) and vertical (b) planes at the center of the tumor. Results are presented as the means ± standard deviation are described (). The “*” denotes significance ().
